Kringle Pharma (4884) · PolicyRestatedLatest Governance (2026-09-16): "Advanced"
Governance Focused on Corporate and Shareholder Value, Transparency and Fairness
First written in FY2020. 1 of 3 entries say "Restated". Latest entry: 2026-09-16.
3entries
7years
1from disclosures
How it moved
Same theme, other companies
Continuous Strengthening of Corporate Governance and Internal Control SystemsA theme 969 companies write about · 4 as a headwind · 1069 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 185 companies compared. The sentences above are computed from all 185.Comparing 200 of the theme's 1075 threads.Full recordFilings, disclosures and news, newest first
- 2026-09-16AdvancedGovernance
「開発ステージの進展に伴う事業化準備の本格化および海外展開の拡大を見据え、研究開発、製造、事業開発等の各専門機能における責任と権限を明確化するとともに、より迅速かつ機動的な業務執行体制を構築するため、執行役員制度を導入することといたしました。これにより、経営基盤の強化と持続的な企業価値向上を目指してまいります。」
企業価値向上と経営基盤の強化を掲げるガバナンス方針について、執行役員制度の導入、専門機能ごとの責任・権限の明確化、業務執行の迅速化という具体的な体制整備へ進展した。 - FY2022RestatedAnnual report
「We believe it is necessary to maximize corporate and shareholder value while accelerating decision-making and enhancing management transparency and fairness.」
企業価値・株主価値、意思決定の迅速性、透明性・公正性を重視するガバナンス方針を再掲している。 - FY2020First statedAnnual report
「We believe it is necessary to maximize corporate and shareholder value while accelerating decision-making and enhancing management transparency and fairness.」
The company aims to enhance corporate and shareholder value, transparency and fairness, with the goal of continuing to be supported by all stakeholders as a valuable company.